Dealing With Complex Overactive Bladder Syndrome Patient Profiles With Focus on Fesoterodine: In or Out of the EAU Guidelines?

Research and Reports in Urology - New Zealand
doi 10.2147/rru.s146746
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Informa UK Limited

Related search

Overactive Bladder: Symptom or Syndrome?

BJU International
Urology
2003English

Perceptions of “Urgency” in Women With Interstitial Cystitis/Bladder Pain Syndrome or Overactive Bladder

Neurourology and Urodynamics
NeurologyUrology
2010English

Does Fesoterodine Have a Role in the Treatment of Poorly Managed Patients With Overactive Bladder?

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Somatic Comorbidity in Women With Overactive Bladder Syndrome

Journal of Urology
Urology
2016English

Factors Associated With Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)

Advances in Therapy
MedicinePharmacology
2019English

Affective Temperament Profiles of Overactive Bladder Patients

Noropsikiyatri Arsivi
PsychiatryNeuroscienceMental Health
2016English

The Effects of Tolterodine on Anterior Segment and Choroidal Thickness in Patients With Overactive Bladder Syndrome

Therapeutic Advances in Urology
Urology
2017English

New Developments in the Management of Overactive Bladder: Focus on Mirabegron and onabotulinumtoxinA

Therapeutics and Clinical Risk Management
2013English

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome

International Neurourology Journal
NeurologyUrology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy